SEC Form 4/A · accession 0001127602-15-027882

ARIAD PHARMACEUTICALS INC · ARIA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — SVP, Chief IP Counsel

Period of report

Sep 24, 2015

Accepted (ET)

Sep 30, 2015 · 4:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000884731

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 24, 2015	M	10,000	$0.00	A	240,449	D
Common Stock^F3	Sep 28, 2015	S	5,000	$6.4631	D	235,449	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Performance stock unit^F4,F5	—	Sep 24, 2015	M	10,000	D	—	—	Common Stock	10,000	10,000	D
Performance stock unit^F4,F5	—	Sep 24, 2015	A	20,000	A	—	—	Common Stock	20,000	20,000	D

F1Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
F2Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.22 to $6.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
F4Each performance stock unit represents a right to receive one share of ARIAD common stock.
F5The performance stock units vest as to 50% of the award on 9/24/2015 and 50% of the award on 9/24/2016.

The purpose of this amendment is to correct the Amount of Securities Beneficially Owned in Table 1.